Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinib

Lignende værker

• Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma
  af: Patil, Vijay Maruti, et al.
  Udgivet: (2017)
• Efficacy and Safety Evaluation of Intrathecal Pemetrexed in EGFR-mutated NSCLC Patients 
with Leptomeningeal Metastases
  af: Tianli ZHANG, et al.
  Udgivet: (2025-08-01)
• Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction
  af: Wang, Wen-Ping, et al.
  Udgivet: (2012)
• Case report: A case report and literature review on the efficacy of high-dose aumolertinib combined intrathecal pemetrexed by Ommaya reservoir for EGFR-mutated NSCLC with leptomeningeal metastasis as the initial symptoms
  af: Maoxi Zhong, et al.
  Udgivet: (2025-01-01)
• First-line osimertinib for leptomeningeal metastasis from lung adenocarcinoma with EGFR mutation as the initial and solitary site of postoperative recurrence
  af: Ono, Yuki, et al.
  Udgivet: (2020)